...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
【24h】

Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.

机译:鉴定和表达引起假丝酵母念珠菌耐氟康唑的多药转运蛋白。

获取原文
获取原文并翻译 | 示例

摘要

Candida dubliniensis is a recently described Candida species associated with oral candidosis in human immunodeficiency virus (HIV)-infected and AIDS patients, from whom fluconazole-resistant clinical isolates have been previously recovered. Furthermore, derivatives exhibiting a stable fluconazole-resistant phenotype have been readily generated in vitro from fluconazole-susceptible isolates following exposure to the drug. In this study, fluconazole-resistant isolates accumulated up to 80% less [3H] fluconazole than susceptible isolates and also exhibited reduced susceptibility to the metabolic inhibitors 4-nitroquinoline-N-oxide and methotrexate. These findings suggested that C. dubliniensis may encode multidrug transporters similar to those encoded by the C. albicans MDR1, CDR1, and CDR2 genes (CaMDR1, CaCDR1, and CaCDR2, respectively). A C. dubliniensis homolog of CaMDR1, termed CdMDR1, was cloned; its nucleotide sequence was found to be 92% identical to the corresponding CaMDR1 sequence, while the predicted CdMDR1 protein was found to be 96% identical to the corresponding CaMDR1 protein. By PCR, C. dubliniensis was also found to encode homologs of CDR1 and CDR2, termed CdCDR1 and CdCDR2, respectively. Expression of CdMDR1 in a fluconazole-susceptible delta pdr5 null mutant of Saccharomyces cerevisiae conferred a fluconazole-resistant phenotype and resulted in a 75% decrease in accumulation of [3H]fluconazole. Northern analysis of fluconazole-susceptible and -resistant isolates of C. dubliniensis revealed that fluconazole resistance was associated with increased expression of CdMDR1 mRNA. In contrast, most studies showed that overexpression of CaCDR1 was associated with fluconazole resistance in C. albicans. Increased levels of the CdMdr1p protein were also detected in fluconazole-resistant isolates. Similar results were obtained with fluconazole-resistant derivatives of C. dubliniensis generated in vitro, some of which also exhibited increased levels of CdCDR1 mRNA and CdCdr1p protein. These results demonstrate that C. dubliniensis encodes multidrug transporters which mediate fluconazole resistance in clinical isolates and which can be rapidly mobilized, at least in vitro, on exposure to fluconazole.
机译:dubliniensis念珠菌是最近描述的与人类免疫缺陷病毒(HIV)感染和AIDS患者的口腔念珠菌病相关的念珠菌,先前已从中回收了耐氟康唑的临床分离株。此外,暴露于药物后,容易从氟康唑敏感性分离物中体外产生表现出稳定的氟康唑抗性表型的衍生物。在这项研究中,耐氟康唑的菌株比易感菌株分离出的[3H]氟康唑的累积量最多减少80%,并且对代谢抑制剂4-硝基喹啉-N-氧化物和甲氨蝶呤的敏感性降低。这些发现表明,dubliniensis可能编码与白色念珠菌MDR1,CDR1和CDR2基因(分别为CaMDR1,CaCDR1和CaCDR2)编码的多药转运蛋白相似的转运蛋白。克隆了CaMDR1的C. dubliniensis同源物CdMDR1;发现其核苷酸序列与相应的CaMDR1序列92%相同,而预测的CdMDR1蛋白与相应的CaMDR1蛋白96%相同。通过PCR,还发现杜氏梭菌编码CDR1和CDR2的同源物,分别称为CdCDR1和CdCDR2。 CdMDR1在酿酒酵母的氟康唑敏感性δpdr5空突变体中的表达赋予氟康唑抗性表型,并导致[3H]氟康唑的积累减少75%。对氟康唑敏感性和抗药性的杜氏梭状芽胞杆菌的Northern分析表明,氟康唑抗性与CdMDR1 mRNA表达增加有关。相反,大多数研究表明,CaCDR1的过表达与白色念珠菌对氟康唑的耐药性有关。在耐氟康唑的分离物中也检测到CdMdr1p蛋白水平升高。体外产生的耐氟康唑的杜氏梭菌衍生物获得了相似的结果,其中一些还表现出CdCDR1 mRNA和CdCdr1p蛋白水平升高。这些结果表明,杜氏梭菌编码多种药物转运蛋白,其介导临床分离物中的氟康唑抗性,并且在暴露于氟康唑时至少在体外可以快速动员。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号